Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Predictors of the Utilization and Waiting Period Before Starting an Oncological Rehabilitation after Breast Cancer].
Noeres D, Sperlich S, Röbbel L, Safieddine B, Deuker JU, Hillemanns P, Ismaéel F, Moser A, Noeding KH, Noesselt T, Pape J, Park-Simon TW, Peschel S, Seifert W, Siggelkow W, Thoma M, Uleer C, Geyer S. Noeres D, et al. Among authors: peschel s. Rehabilitation (Stuttg). 2021 Apr;60(2):86-94. doi: 10.1055/a-1361-4028. Epub 2021 Apr 15. Rehabilitation (Stuttg). 2021. PMID: 33858017 German.
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
Bernhardt S, Bayerlová M, Vetter M, Wachter A, Mitra D, Hanf V, Lantzsch T, Uleer C, Peschel S, John J, Buchmann J, Weigert E, Bürrig KF, Thomssen C, Korf U, Beissbarth T, Wiemann S, Kantelhardt EJ. Bernhardt S, et al. Among authors: peschel s. Breast Cancer Res. 2017 Oct 11;19(1):112. doi: 10.1186/s13058-017-0905-7. Breast Cancer Res. 2017. PMID: 29020998 Free PMC article. Clinical Trial.
PIK3CA-mutations in breast cancer.
Reinhardt K, Stückrath K, Hartung C, Kaufhold S, Uleer C, Hanf V, Lantzsch T, Peschel S, John J, Pöhler M, Bauer M, Bürrig FK, Weigert E, Buchmann J, Kantelhardt EJ, Thomssen C, Vetter M. Reinhardt K, et al. Among authors: peschel s. Breast Cancer Res Treat. 2022 Dec;196(3):483-493. doi: 10.1007/s10549-022-06637-w. Epub 2022 Oct 24. Breast Cancer Res Treat. 2022. PMID: 36279023 Free PMC article.
Prognostic and predictive impact of NOTCH1 in early breast cancer.
Engel J, Wieder V, Bauer M, Kaufhold S, Stückrath K, Wilke J, Hanf V, Uleer C, Lantzsch T, Peschel S, John J, Pöhler M, Weigert E, Bürrig KF, Buchmann J, Santos P, Kantelhardt EJ, Thomssen C, Vetter M. Engel J, et al. Among authors: peschel s. Breast Cancer Res Treat. 2024 Aug 17. doi: 10.1007/s10549-024-07444-1. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39153127
Correction: Prognostic and predictive impact of NOTCH1 in early breast cancer.
Engel J, Wieder V, Bauer M, Kaufhold S, Stückrath K, Wilke J, Hanf V, Uleer C, Lantzsch T, Peschel S, John J, Pöhler M, Weigert E, Bürrig KF, Buchmann J, Santos P, Kantelhardt EJ, Thomssen C, Vetter M. Engel J, et al. Among authors: peschel s. Breast Cancer Res Treat. 2024 Nov 20. doi: 10.1007/s10549-024-07520-6. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39565513 No abstract available.
Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients.
Bauer M, Kantelhardt EJ, Stiewe T, Nist A, Mernberger M, Politt K, Hanf V, Lantzsch T, Uleer C, Peschel S, John J, Buchmann J, Weigert E, Bürrig KF, Wickenhauser C, Thomssen C, Bartel F, Vetter M. Bauer M, et al. Among authors: peschel s. Oncotarget. 2019 Mar 8;10(20):1975-1992. doi: 10.18632/oncotarget.26768. eCollection 2019 Mar 8. Oncotarget. 2019. PMID: 30956778 Free PMC article.
Use of social service counseling by cancer patients: an analysis of quality assurance data of 6339 breast cancer patients from 13 certified centers in Germany treated between 2015 and 2017.
Breidenbach C, Wesselmann S, Sibert NT, Ortmann O, Blankenburg K, Stoklossa C, Gebauer G, Dos Santos Guilherme M, Lindner C, Peschel S, Schad F, Strecker P, Rieger L, Ferencz J, Dieng S, Kowalski C. Breidenbach C, et al. Among authors: peschel s. BMC Cancer. 2021 Jun 5;21(1):671. doi: 10.1186/s12885-021-08396-1. BMC Cancer. 2021. PMID: 34090379 Free PMC article.
Identifying High-Risk Triple-Negative Breast Cancer Patients by Molecular Subtyping.
Hartung C, Porsch M, Stückrath K, Kaufhold S, Staege MS, Hanf V, Lantzsch T, Uleer C, Peschel S, John J, Pöhler M, Weigert E, Buchmann J, Bürrig KF, Schüler K, Bethmann D, Große I, Kantelhardt EJ, Thomssen C, Vetter M. Hartung C, et al. Among authors: peschel s. Breast Care (Basel). 2021 Dec;16(6):637-647. doi: 10.1159/000519255. Epub 2021 Oct 19. Breast Care (Basel). 2021. PMID: 35082572 Free PMC article.
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer Patients.
Schüler K, Bethmann D, Kaufhold S, Hartung C, Stückrath K, Lantzsch T, Uleer C, Hanf V, Peschel S, John J, Pöhler M, Buchmann J, Bürrig KF, Weigert E, Thomssen C, Kantelhardt EJ, Vetter M. Schüler K, et al. Among authors: peschel s. Diagnostics (Basel). 2022 Oct 18;12(10):2527. doi: 10.3390/diagnostics12102527. Diagnostics (Basel). 2022. PMID: 36292215 Free PMC article.
Trastuzumab treatment of patients with early, HER2-positive breast cancer in 17 certified German breast cancer centers.
Sibert NT, Wesselmann S, Breidenbach C, Blohmer J, Brückner B, Gebauer G, Dos Santos Guilherme M, Hartkopf A, Lindner C, Peschel S, Rieger L, Schad F, Strecker P, Ferencz J, Dieng S, Inwald EC, Kowalski C, Ortmann O. Sibert NT, et al. Among authors: peschel s. J Cancer Res Clin Oncol. 2022 Mar;148(3):719-726. doi: 10.1007/s00432-021-03651-1. Epub 2021 Apr 29. J Cancer Res Clin Oncol. 2022. PMID: 33914125
48 results